Publications found:
253,569
Sort by:
Insulin Delivery Systems Market Forecast to 2014
US$ 1,400.00
The global medical fraternity is alarmed at the rate at which the diabetic population has been increasing worldwide. It is expected that the number of diabetic patients in the world will reach around...
February 2012
90 pages
Japan Generics Market Analysis
US$ 1,000.00
Japan is the world’s second largest pharmaceutical markets in the world, but due to public perception, the share of generic drugs has remained low in it. However, worried over rising healthcare expens...
February 2012
55 pages
Global Heart Valve Market Report: 2011 Edition
US$ 800.00
... obesity are the major factors which are driving the global heart valve market growth. Moreover, rising urban population which leads ... report provides an analysis of the global heart valve market. It also discusses the major trends, growth drivers and potential markets for heart valve market. The report ...
February 2012
35 pages
Canada’s Biotechnology Industry - Porter’s Five Forces Strategy Analysis
US$ 175.00
... is a critical element of national power. Advances in biotechnology are resulting in novel biomedical and pharmaceutical products and processes ... the world’s citizens. Aruvian's R'search analyzes the Canadian Biotechnology industry in the Michael Porter’s Five Forces Analysis. It uses concepts developed in ...
February 2012
20 pages
Japan’s Biotechnology Industry - Porter’s Five Forces Strategy Analysis
US$ 175.00
... is a critical element of national power. Advances in biotechnology are resulting in novel biomedical and pharmaceutical products and processes ... the world’s citizens. Aruvian's R'search analyzes the Japanese Biotechnology Industry in the Michael Porter’s Five Forces Analysis. It uses concepts developed in ...
February 2012
20 pages
Drug Industry in the United States - Porter’s Five Forces Strategy Analysis
US$ 175.00
... falling, leading to layoffs and cuts in research budgets. While the US drug industry is hardly in a full-blown crisis, however, layoffs are occurring ... taken once a week instead of daily. Aruvian's R'search analyzes the United States Drug Industry in the Michael Porter’s Five Forces Analysis. It uses concepts ...
February 2012
12 pages
Analyzing the Global Pharmaceutical Industry
US$ 450.00
... corporate enterprises. Aruvian's R'search’s report – Analyzing the Global Pharmaceutical Industry - presents a complete analysis of the global pharmaceutical industry by setting up a industry demarcation and ...
February 2012
480 pages
Looking at Bioinformatics – IT’s Human Touch
US$ 275.00
... ranging industries and research applications. The growing acceptance of Bioinformatics as an important field requiring focused commercial support and ... in order to expand the service bases. Aruvian's R'search’s report – Looking at Bioinformatics – IT’s Human Touch - is a analytical docket on the Bio Informatics ...
February 2012
85 pages
Pharmaceutical Industry in China
US$ 325.00
... the government in the industry, and investment opportunities in China’s Pharmaceutical Industry. Complete with a comprehensive section on the clinical ... players in the Chinese Pharmaceutical Industry, Aruvian’s latest research is a collection of all you need to know about China’s Pharmaceutical Industry.
February 2012
80 pages
Pharmaceutical Industry in China – PEST Framework Analysis
US$ 175.00
... manufacturing technology and management structure. The Chinese pharmaceutical industry also has a lower market concentration and ... competitiveness, coupled with a lack of patented pharmaceuticals developed in-house. Aruvian's R'search analyzes Pharmaceutical Industry in China in a PEST Framework Analysis. A PEST ...
February 2012
25 pages
Pharmaceutical Industry in Mexico
US$ 325.00
... cellular and molecular levels to dramatically advance the treatment of disease. Mexico’s pharmaceutical policy environment is in a period of rapid evolution, with simultaneous policy development ...
February 2012
120 pages
Pharmaceutical Industry in Poland
US$ 300.00
... on healthcare as economies boomed globally. The global presence of the pharmaceutical industry is evident with the roll out of continent specific R&D ... of hospitalization. Aruvian’s R’search brings you a complete analysis of the Pharmaceutical Industry in Denmark. The report covers a brief profile of the global ...
February 2012
100 pages
Pharmaceutical Industry in Denmark
US$ 300.00
... a complete analysis of the Pharmaceutical Industry in Denmark. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Denmark – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Pharmaceutical Industry in Sweden
US$ 300.00
... a complete analysis of the Pharmaceutical Industry in Sweden. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Sweden – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Pharmaceutical Industry in Japan
US$ 300.00
... you a complete analysis of the Pharmaceutical Industry in Japan. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Japan – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Pharmaceutical Industry in Spain
US$ 300.00
... you a complete analysis of the Pharmaceutical Industry in Spain. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Spain – complete with a SWOT analysis of the leading companies in ...
February 2012
145 pages
Pharmaceutical Industry in South Korea
US$ 300.00
... a complete analysis of the Pharmaceutical Industry in South Korea. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement ... competition in the industry, and the key players in the pharmaceutical industry in South Korea – complete with a SWOT analysis of the leading companies ...
February 2012
100 pages
Pharmaceutical Industry in the Netherlands
US$ 300.00
... . Aruvian’s R’search brings you a complete analysis of the Pharmaceutical Industry in The Netherlands. The report covers a brief profile of the global ... competition in the industry, and the key players in the pharmaceutical industry in the Netherlands – complete with a SWOT analysis of the leading companies ...
February 2012
100 pages
Pharmaceutical Industry in Brazil
US$ 300.00
... a complete analysis of the Pharmaceutical Industry in Brazil. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Brazil – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Pharmaceutical Industry in Norway
US$ 300.00
... a complete analysis of the Pharmaceutical Industry in Norway. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Norway – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Pharmaceutical Industry in Taiwan
US$ 300.00
... a complete analysis of the Pharmaceutical Industry in Taiwan. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Taiwan – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Pharmaceutical Industry in Hungary
US$ 300.00
... a complete analysis of the Pharmaceutical Industry in Hungary. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Hungary – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Pharmaceutical Industry in Belgium
US$ 300.00
... a complete analysis of the Pharmaceutical Industry in Belgium. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Belgium – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Pharmaceutical Industry in Germany
US$ 300.00
... a complete analysis of the Pharmaceutical Industry in Germany. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Germany – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Pharmaceutical Industry in Russia
US$ 300.00
... a complete analysis of the Pharmaceutical Industry in Russia. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Russia – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Pharmaceutical Industry in Czech Republic
US$ 300.00
... complete analysis of the Pharmaceutical Industry in Czech Republic. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement ... in the industry, and the key players in the pharmaceutical industry in Czech Republic – complete with a SWOT analysis of the leading companies ...
February 2012
100 pages
Pharmaceutical Industry in South Africa
US$ 300.00
... complete analysis of the Pharmaceutical Industry in South Africa. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement ... in the industry, and the key players in the pharmaceutical industry in South Africa – complete with a SWOT analysis of the leading companies ...
February 2012
100 pages
Pharmaceutical Industry in Italy
US$ 300.00
... you a complete analysis of the Pharmaceutical Industry in Italy. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Italy – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Competitor Analysis: Anti-Obesity Peptides and Biologics
US$ 262.00
... peptides and biologics as of February 2012. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and ... . In addition, the report lists company-specific R&D pipelines of anti-obesity peptides and biologics. Competitor projects are listed in a tabular format providing ...
February 2012
28 pages
Biosensors in Medical Diagnostics: Market Research Report
US$ 4,500.00
This report analyzes the worldwide markets for Biosensors in Medical Diagnostics in US$ Million by the following Product Segments: Medical Biosensors, Glucose Biosensors, Other Medical Biosensors, Environmental Biosensors, and Other Biosensors. The report provides separate comprehensive analytics for the US, ...
January 2012
423 pages
Gene Amplification Technologies: Market Research Report
US$ 4,500.00
This report analyzes the worldwide markets for Gene Amplification Technologies in US$ Million by the following Product Segments: Polymerase Chain Reaction, and Other ... Corp., QIAGEN N.V, Roche Diagnostics, Rubicon Genomics, and Takara Bio, Inc. Market data and analytics are derived from primary and secondary ...
January 2012
529 pages
Gene Therapy: Market Research Report
US$ 4,500.00
This report analyzes the Global market for Gene Therapy in US$ Million. Annual estimates and forecasts are provided for the period 2009 through ... GenVec, Oxford BioMedica, Shenzhen SiBiono GeneTech Co., Ltd., Transgene, and Vical Inc. Market data and analytics are derived from primary and secondary research. ...
January 2012
459 pages
Gums: Market Research Report
US$ 4,500.00
This report analyzes the worldwide markets for Gums in US$ Million by the following Product Segments: Chewing Gum, and Bubble Gum. The report provides separate ... 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 126 companies including many key and niche ...
January 2012
304 pages
Meeting KOL Needs: What Pharma Needs to Know
US$ 1,445.00
The role of the Key Opinion Leader (KOL) has changed over the past 30 years. And it's about to change again.Once viewed with suspicion by their non-consulting peers, clinicians are now considered less...
January 2012
108 pages
Tiered Pricing Strategies in Emerging Markets
US$ 695.00
For the pharmaceutical industry, emerging markets are dynamic, full of potential and offer solid growth at a time when established markets are contracting. But they also pose a significant problem: ex...
January 2012
93 pages
IPCA - Awaiting Re-rating
US$ 140.00
... visibility in sales growth and margin improvement, the stock simply awaits re-rating. Going forward, earnings will be driven by (1) domestic market ... and FY13 earnings by 5-6%. At current valuation, IPCA trades at a PE of 10x on FY13 earnings. This makes IPCA the cheapest stock available with a sustainable ...
January 2012
5 pages
ROCHE - Erivedge (Vismodegib) approved for Locally Advanced or Metastatic BCC in US
US$ 90.00
... , ROG and Curis jointly announced that the USFDA approved once daily Erivedge, oral, first in class hedgehog inhibitor earlier than ... to be approved for this indication. Erivedge will be available in specialty pharmacies in US within one or two weeks. Roche has the marketing rights for Vismodegib excluding ...
January 2012
5 pages
BMY 4Q-11 Results – Patent expiry pains reflecting in the guidance
US$ 90.00
Post today’s announcement of 4Q-11 results, we reiterate our underperform rating on BMY with a PT of $26. The 2012 EPS guidance range of $1.9 - $2.0 is ... reflective of the towering pressures, while valuation continues to remain soaring. BMY holds a promising HCV pipeline, but seems priced to perfection. Yeryoy ...
January 2012
1 pages
LUPIN - Generic Tricor To Offer a Cushion Against Suprax Generic Erosion
US$ 140.00
... multiple years. In addition, there is a strong likelihood that Lupin may remain the only generic player for some time – something that we have ... for Suprax from FY13 to FY14 and (2) estimating $40m from generic Tricor in FY14 (to be launched in Q4 FY13). We upgrade our target price to Rs.463 by applying ...
January 2012
6 pages
NOVARTIS
US$ 90.00
For the fourth quarter 2011, in line with our expectations, NVS Sales grew 5%, and core EPS advanced 8%. NVS also announced full year dividend for 2011 at CHF 2.25, which translates into a meager 2%, increase, which we think is a dampener. The 2012 guidance as well was lackluster as NVS expects net sales in ...
January 2012
2 pages
Global Telemedicine Market Analysis
US$ 1,200.00
Telemedicine enables in providing interactive healthcare utilizing modern technology and telecommunication. The global telemedicine industry has been growing stupendously over the past few years with...
January 2012
65 pages
Global Genetic Testing Market Analysis
US$ 1,200.00
As the foundation of providing superior healthcare lies in diagnosis, genetic testing represents a highly attractive segment in molecular diagnostics market. Genetic testing is a sophisticated form of...
January 2012
65 pages
Global Cosmeceuticals Market Analysis
US$ 1,400.00
Cosmeceuticals are the latest addition to the health industry and are described as cosmetic products with drug-like benefits. With the rise of more knowledgeable, wealthy, and beauty-conscious class o...
January 2012
70 pages
